Antibiotics for Postpartum Third and Fourth Degree Perineal Tear Repairs
NCT ID: NCT00186082
Last Updated: 2011-06-15
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
147 participants
INTERVENTIONAL
2003-09-30
2008-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Prophylactic Antibiotic After Perineal Tear
NCT04763486
Oral Antibiotics After Obstetric Perineal Tear
NCT05830162
Antibiotics for Severe Perineal Laceration to Prevent Infection Following Repair
NCT04573504
Surgical Site Infection After Episiotomy Repair Related to Routine Use of Antibiotic Prophylaxis in Low-Risk Population
NCT06154720
A Randomized, Controlled Trial of the Effectiveness of Perioperative Antibiotics for Reduction of Burn Wound Bacterial Concentration Following Grafting
NCT04516148
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
SINGLE_GROUP
PREVENTION
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Cefotetan, Cefoxitin or Clindamycin
Cefotetan or Cefoxitin vs placebo
Cefotetan or Cefoxitin, 1 g intravenously, or Clindamycin, 900 mg intravenously.
Normal Saline, 100 ml intravenously for placebo arm.
Normal Saline
Cefotetan or Cefoxitin vs placebo
Cefotetan or Cefoxitin, 1 g intravenously, or Clindamycin, 900 mg intravenously.
Normal Saline, 100 ml intravenously for placebo arm.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Cefotetan or Cefoxitin vs placebo
Cefotetan or Cefoxitin, 1 g intravenously, or Clindamycin, 900 mg intravenously.
Normal Saline, 100 ml intravenously for placebo arm.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Santa Clara Valley Health & Hospital System
OTHER
Stanford University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Stanford University School of Medicine
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Yasser Yehia El-Sayed
Role: PRINCIPAL_INVESTIGATOR
Stanford University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Santa Clara Valley Medical Center
San Jose, California, United States
Stanford University School of Medicine
Stanford, California, United States
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Duggal N, Mercado C, Daniels K, Bujor A, Caughey AB, El-Sayed YY. Antibiotic prophylaxis for prevention of postpartum perineal wound complications: a randomized controlled trial. Obstet Gynecol. 2008 Jun;111(6):1268-73. doi: 10.1097/AOG.0b013e31816de8ad.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
95339
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.